Education
About Us
Working with TipRanks
Follow Us
DocGo (DCGO)
NASDAQ:DCGO
DCGO Stock Chart & Stats
$1.16
-$0.06(-1.42%)
At close: 4:00 PM EST
$1.16
-$0.06(-1.42%)
Day’s Range― - ―
52-Week Range$1.12 - $5.68
Previous CloseN/A
Volume125.49K
Average Volume (3M)654.35K
Market Cap
$113.46M
Enterprise Value$102.06M
Total Cash (Recent Filing)$104.16M
Total Debt (Recent Filing)$60.45M
Price to Earnings (P/E)12.7
Beta0.89
Next Earnings
Nov 10, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding97,808,136
10 Day Avg. Volume1,101,531
30 Day Avg. Volume654,346
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.35
Price to Sales (P/S)0.70
P/FCF Ratio6.73
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda-8.16
Forecast
1Y Price Target
$3.15Price Target Upside171.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
Bulls Say, Bears Say
Bulls Say
Business OpportunitiesDocGo is in contract talks with 2 national payers and discussions with others representing 35 potential deals, which could enhance business opportunities.
Financial StabilityDocGo has collected a substantial portion of its receivables related to the NY migrant contract, paid off its credit facility, and expects to have over $110 million in cash and investments, providing financial stability.
Growth In Managed LivesDCGO currently has 1.2M+ assigned lives for care gap closures compared to 900K a quarter ago, showing growth in managed lives.
Bears Say
Core Revenue ChallengesThere remains substantial work to do to grow core revenue and rightsize the cost structure to return to profitability.
EBITDA And Revenue PressureThe return to positive EBITDA will take time, as adjusted EBITDA declined sequentially and results have been inconsistent.
Transportation RevenueTransportation revenue was disappointing, down 2.3% sequentially, creating challenges to achieve the growth target.
DocGo News
DCGO FAQ
What was DocGo’s price range in the past 12 months?
DocGo lowest stock price was $1.12 and its highest was $5.67 in the past 12 months.
What is DocGo’s market cap?
DocGo’s market cap is $113.46M.
When is DocGo’s upcoming earnings report date?
DocGo’s upcoming earnings report date is Nov 10, 2025 which is in 21 days.
How were DocGo’s earnings last quarter?
DocGo released its earnings results on Aug 07, 2025. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.01.
Is DocGo overvalued?
According to Wall Street analysts DocGo’s price is currently Undervalued.
Does DocGo pay dividends?
DocGo does not currently pay dividends.
What is DocGo’s EPS estimate?
DocGo’s EPS estimate is -0.13.
How many shares outstanding does DocGo have?
DocGo has 97,808,136 shares outstanding.
What happened to DocGo’s price movement after its last earnings report?
DocGo reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went up 12.95%.
Which hedge fund is a major shareholder of DocGo?
Currently, no hedge funds are holding shares in DCGO
DocGo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.15 (171.55% Upside)
$3.15 (171.55% Upside)
Blogger Sentiment
Neutral
DCGO Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 232.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 3.1%
Last 30 Days ▼ 3.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.78%
12-Months-Change
Fundamentals
Return on Equity
-5.98%
Trailing 12-Months
Asset Growth
-16.37%
Trailing 12-Months
Company Description
DocGo
DocGo (DCGO) is a leading provider of mobile health services and innovative healthcare solutions, primarily operating within the telehealth and healthcare logistics sectors. The company specializes in delivering high-quality healthcare services directly to patients at home or in remote locations, leveraging technology to enhance patient care. Its core offerings include on-site medical services, telehealth consultations, and patient transport services, aimed at improving access to care and optimizing healthcare delivery.
DCGO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, including strong cash flow, significant SG&A cost reductions, and growth in key business areas such as the care gap closure program and medical transportation. However, these were offset by a substantial decline in overall revenue and a negative EBITDA, mainly due to the wind down of migrant-related projects. The company is focusing on leveraging its strong balance sheet and operational efficiencies to drive future growth.View all DCGO earnings summariesDCGO Stock 12 Month Forecast
Average Price Target
$3.15
▲(171.55% Upside)
Technical Analysis
Ownership Overview
4.81% Insiders
9.65% Mutual Funds
0.10% Other Institutional Investors
75.88% Public Companies and
Individual Investors